DIAGNOS Inc.

Equities

ADK

CA2524423068

IT Services & Consulting

Market Closed - Toronto S.E. 03:50:43 2024-03-27 pm EDT 5-day change 1st Jan Change
0.235 CAD -6.00% Intraday chart for DIAGNOS Inc. -6.00% -41.98%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units MT
DIAGNOS Inc. announced that it has received CAD 0.578 million in funding CI
Diagnos Announces Grant Of Stock Options MT
DIAGNOS Inc. Appoints Michael Braeuel to Board of Directors CI
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
DIAGNOS Announces Closing Of First Tranche Of Private Placement MT
DIAGNOS Inc. announced that it expects to receive CAD 1.19244 million in funding CI
Diagnos Inc. Appoints Yves-Stéphane Couture as Chief Operating Officer CI
Diagnos Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica MT
Diagnos Inc. Secures Exclusive Distribution Agreement for Canada with Essilorluxottica CI
DIAGNOS Inc. announced that it has received CAD 0.640051 million in funding CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
DIAGNOS Inc. Announces Commencement of its Innovative Deployment in an Advanced Screening Program At Canada's Presented Specialist Care Provider in Diabetes and Endocrinology CI
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
DIAGNOS Inc. Auditor Raises 'Going Concern' Doubt CI
Diagnos Raises C$865,000 in Private Placement of Convertible Debentures and Warrants MT
DIAGNOS Inc. announced that it has received CAD 0.865 million in funding CI
Diagnos Announces Launch of "IRIS-ai powered by DIAGNOS" MT
DIAGNOS Inc. and IRIS, The Visual Group Strengthens Partnership with the Launch of "IRIS-ai Powered by DIAGNOS" CI
Diagnos and ETS Unveil Method to Adapt Deep Learning Algorithms MT
DIAGNOS and ETS to Present Research on Mass Screening for Macular Edema at ARVO 2023 CI
Diagnos Gets OK For the Use of Diabetic Retinopathy Screening Technology in Quebec Hospitals MT
Diagnos Inc Gets the Green Light for the Use of Its Diabetic Retinopathy Screening Technology in Quebec Hospitals CI
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Chart DIAGNOS Inc.
More charts
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.235 CAD
Average target price
1.5 CAD
Spread / Average Target
+538.30%
Consensus
  1. Stock
  2. Equities
  3. Stock DIAGNOS Inc. - Toronto S.E.
  4. News DIAGNOS Inc.
  5. Diagnos : Says No Undisclosed Material Information Behind 7% Rise in Shares